This section is from the book "Research In Physiopathology As Basis Of Guided Chemotherapy With Special Application To Cancer", by Emanuel Revici. Also available from amazon: Research In Physiopathology
Though carried out only at the beginning of these studies, the application of this method, conducted by Leonard B. Goldman, M.D. in 1950 and 1951 appears interesting. As part of this investigation, lipids were used in association with radiotherapy. In the same research, a group of patients were also treated with lipids alone. A report on this series was presented by L. Goldman as part of a symposium on the therapy of advanced cancer patients, before the Radiological Section of the American Medical Association at its annual convention in Atlantic City on June 14, 1951 (327). His results with patients treated with X ray and lipids and with lipid therapy alone are summarized in Table XVIA and XVIB.
Type of Malignancy | Total Number | Number | Relief of Symptoms | Marked | Temporary Arrest | Regression | |
Slight | Moderate | ||||||
Breast | 8 | 7 | 2 | 1 | 4 | 5 | 2 |
Lymphoblastoma | 7 | 4 | 2 | 1 | 1 | 1 | 0 |
Lung | 6 | 5 | 2 | 0 | 3 | 1 | 1 |
Head and Neck | 11 | 4 | 2 | 0 | 2 | 1 | 1 |
Gastro intestinal | 6 | 4 | 0 | 1 | 3 | 2 | 1 |
Gynecological | 3 | 3 | 1 | 1 | 1 | 1 | 0 |
Genito urinary | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
Sarcoma | 2 | 1 | 0 | 0 | 1 | 0 | 0 |
Miscellaneous | 4 | 2 | 1 | 0 | 1 | 1 | 1 |
Total | 50 | 30 | 10 | 4 | 16 | 12 | 6 |
(60%) | (24%) | (12%) | |||||
Type of Malignancy | Total Number | Number | Relief of Symptoms | Marked | Temporary Arrest | Regression | |
Mod- | |||||||
Slight | erate | ||||||
Breast | 14 | 7 | 1 | 0 | 6 | 2 | 2 |
Lymphoblastoma | 8 | 5 | 0 | 0 | 5 | 3 | 2 |
Lung | 3 | 3 | 0 | 0 | 3 | 0 | 0 |
Head and Neck | 3 | 2 | 1 | 0 | 1 | 0 | 0 |
Gastro intestinal | 6 | 3 | 1 | 1 | I | 0 | 0 |
Gynecological | 3 | 1 | 0 | 0 | 1 | 1 | 1 |
Sarcoma | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Miscellaneous | 2 | 2 | 0 | 0 | 2 | 1 | 1 |
Total | 40 | 23 | 3 | 1 | 19 | 7 | 6 |
(58%) | (18%) | (15%) | |||||
 
Continue to: